article · Journal of Blood Medicine
Purpose: To determine the prevalence of vitamin D deficiency (VDD), evaluate its correlation with key hematological parameters, and identify associated factors among patients attending the Sickle Cell Clinic at Mengo Hospital (Kampala, Uganda). Patients and Methods: This cross-sectional study enrolled 213 patients with sickle cell disease (SCD) at Mengo Hospital, serum 25-hydroxyvitamin D levels were measured. Levels were classified as deficient (< 20 ng/mL) or sufficient (≥ 20 ng/mL). Hematological indices, red blood cell (RBC) count, hemoglobin (Hb), and red cell distribution width-coefficient of variation (RDW-CV) were assessed using an automated analyzer, and Spearman correlation was used to assess correlations with vitamin D levels. Multivariable Poisson regression identified variables associated with vitamin D deficiency (VDD), reporting outcomes as adjusted prevalence ratios (aPR). Results: The median age was 10 years (IQR 5– 13); 50.7% were male. The prevalence of vitamin D deficiency (VDD) was 47.4% (95% CI 40.8– 54.2%). Weak but significant positive correlations were observed between serum vitamin D levels and RBC count ( ρ = 0.170, p = 0.013) and Hb concentration ( ρ = 0.157, p = 0.022), while a negative correlation was noted with RDW-CV ( ρ = – 0.162, p = 0.018). Adolescents and adults had a higher prevalence of VDD compared to younger children (12– 17 years; aPR 1.96, p = 0.002) and (≥ 18 years; aPR 3.20, p < 0.001) respectively. Additionally, folic acid and hydroxyurea were associated with a lower risk of VDD (aPR 0.69, p = 0.028). Conclusion: Nearly half of the patients with sickle cell disease had vitamin D deficiency. Older age increased the risk. VDD is weakly but significantly associated with lower Hb/RBC and higher RDW, suggesting a possible contributory role in the hematologic profile of Ugandan SCD patients. Keywords: prevalence, vitamin D deficiency, sickle cell disease, anemia, hematological parameters
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2147/jbm.s621903
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.